Esperion Therapeutics, Inc.

Man Group plc ESPR
Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
339,775
Value ($000)
931
Weight
0.0%
2019 Q4 - 2026 Q1 (18 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).